RE:2020 - My takeMgmt did a lousy job of presenting financials. Q2 to Q3 ebitda went from $16.3 mil to $7.7 mil but Q2 ebitda included $5.0 mil of non-recurring items (COVID relief funds and gain on sale of equip.) which should have never been in an adjusted ebitda calc. Bozos shot themselves in the foot.